ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Fast Data Insights Improve Productivity, Client Centricity

  Discover how Medidata's Rave CTMS seamlessly met the comprehensive requirements of Catalyst Clinical Research—an exclusive CRO provider specializing in oncology—during a period of rapid expansion.

• Effective Use Of IRT In Decentralized And Hybrid Clinical Trials

  Uncover the ways interactive response technologies are helping trial sponsors manage the distribution of medications, forecast trial supply, and integrate workflows with other technology platforms.

• Why More Sponsors Are Taking Control Of Clinical Trial Study Builds

  Accelerate study startup and reduce rework by building studies directly in EDC. Discover a more flexible, efficient approach to managing clinical trials and data quality.

• Top HEOR Trends

  Real-world evidence (RWE) offers insights into the effectiveness of medical treatments in everyday settings, with various stakeholders utilize RWE to enhance healthcare.

• Why Open API Architecture Matters In Clinical Research

  Clinical trials need flexible workflows, but layered integrations add complexity. Open APIs enable real-time data exchange so processes adapt without fragile dependencies or added overhead.

• Combining Patient-Centric Technology and RWD For Comprehensive Evidence

  Explore how by combining digital technologies with secondary RWD, researchers can gather a more holistic understanding of the patient. 

• How Analytics Are Shaping The Future Of Clinical Trial Risk Management

  Explore how analytics are revolutionizing clinical trial risk management and shaping the future of risk mitigation.

• The Hidden Cost Of Preferred Vendors

  Familiar vendors offer comfort — but at the cost of innovation, fit, and fresh thinking. Ease shouldn’t outweigh excellence when selecting partners for your clinical trial.

• The Impact Of Automation In The Monitoring And Reporting Process

  As clinical trial costs rise and ROIs decline, research teams are turning to automation to streamline monitoring and reporting processes without compromising data quality or regulatory compliance.

   

• Where PRO Strategy Goes Wrong

  PRO and COA strategy is now central to trial success. Organizations that capture meaningful patient experience data will gain stronger evidence and a regulatory advantage.